• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染性心内膜炎患者的院内死亡率预测因素:越南一家三级医院的回顾性分析

In-hospital Mortality Predictors in Patients with Infective Endocarditis: a Retrospective Analysis at a Tertiary Hospital in Vietnam.

作者信息

Dung Bui The, Dan Pham Ngoc, Nhut Nguyen Minh

机构信息

Department of Cardiology, University Medical Center HCMC, Ho Chi Minh City, Vietnam.

Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.

出版信息

Med Arch. 2025;79(3):190-193. doi: 10.5455/medarh.2025.79.190-193.

DOI:10.5455/medarh.2025.79.190-193
PMID:40657340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12253607/
Abstract

BACKGROUND

Infective endocarditis (IE) is a severe disease associated with high in-hospital mortality. Prognostic factors and the independent role of cardiac surgery remain unclear in clinical practice in Vietnam.

OBJECTIVE

To identify factors associated with in-hospital mortality in IE patients and evaluate the independent role of cardiac surgery.

METHODS

This retrospective descriptive-analytical study included 129 patients diagnosed with IE at the University Medical Center Ho Chi Minh City from January 2019 to April 2024. Clinical, laboratory, treatment, and outcome data were collected. Logistic regression analyses were performed to identify mortality predictors.

RESULTS

The in-hospital mortality rate was 16.3%. Univariate analysis identified hepatic failure, septic shock, ventilator-associated pneumonia, disseminated intravascular coagulation (DIC), and absence of surgery as associated factors. In multivariate analysis, septic shock (OR = 22.0; 95% CI: 7.1-68.5) and not undergoing cardiac surgery (OR = 0.07; 95% CI: 0.01-0.43) were independent predictors.

CONCLUSION

In-hospital mortality in IE remains high. Early identification of high-risk patients and improved access to indicated cardiac surgery may enhance prognosi.

摘要

背景

感染性心内膜炎(IE)是一种严重疾病,与较高的院内死亡率相关。在越南的临床实践中,预后因素以及心脏手术的独立作用仍不明确。

目的

确定IE患者院内死亡的相关因素,并评估心脏手术的独立作用。

方法

这项回顾性描述性分析研究纳入了2019年1月至2024年4月在胡志明市大学医学中心诊断为IE的129例患者。收集了临床、实验室、治疗和结局数据。进行逻辑回归分析以确定死亡预测因素。

结果

院内死亡率为16.3%。单因素分析确定肝衰竭、感染性休克、呼吸机相关性肺炎、弥散性血管内凝血(DIC)和未进行手术为相关因素。多因素分析中,感染性休克(OR = 22.0;95%CI:7.1 - 68.5)和未接受心脏手术(OR = 0.07;95%CI:0.01 - 0.43)是独立预测因素。

结论

IE患者的院内死亡率仍然很高。早期识别高危患者并改善接受心脏手术的机会可能会改善预后。

相似文献

1
In-hospital Mortality Predictors in Patients with Infective Endocarditis: a Retrospective Analysis at a Tertiary Hospital in Vietnam.感染性心内膜炎患者的院内死亡率预测因素:越南一家三级医院的回顾性分析
Med Arch. 2025;79(3):190-193. doi: 10.5455/medarh.2025.79.190-193.
2
Optimal timing for early surgery in infective endocarditis: a meta-analysis.感染性心内膜炎早期手术的最佳时机:一项荟萃分析。
Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):336-45. doi: 10.1093/icvts/ivv368. Epub 2015 Dec 17.
3
Early versus late surgical intervention or medical management for infective endocarditis: a systematic review and meta-analysis.感染性心内膜炎的早期与晚期手术干预或药物治疗:一项系统评价和荟萃分析
Heart. 2016 Jun 15;102(12):950-7. doi: 10.1136/heartjnl-2015-308589. Epub 2016 Feb 11.
4
[Impact of a dedicated multidisciplinary committee () on the management and outcome of infective endocarditis in a reference center].[一个专门的多学科委员会()对一家参考中心感染性心内膜炎管理及结局的影响]
Rev Esp Quimioter. 2025 May 27;38(4):294-304. doi: 10.37201/req/020.2025.
5
Serum lactate dehydrogenase level as a predictor of 28-day mortality in critically ill patients with infective endocarditis: a retrospective cohort study from MIMIC IV database.血清乳酸脱氢酶水平作为感染性心内膜炎重症患者28天死亡率的预测指标:一项来自MIMIC IV数据库的回顾性队列研究
Heart Lung. 2025 Jul-Aug;72:74-82. doi: 10.1016/j.hrtlng.2025.04.002. Epub 2025 Apr 9.
6
Antibiotic prophylaxis for preventing bacterial endocarditis following dental procedures.牙科操作后预防细菌性心内膜炎的抗生素预防。
Cochrane Database Syst Rev. 2022 May 10;5(5):CD003813. doi: 10.1002/14651858.CD003813.pub5.
7
Treatment Outcomes for Right-Sided Endocarditis in Intravenous Drug Users: A Systematic Review and Analysis of Outcomes in a Tertiary Centre.静脉吸毒者右侧心内膜炎的治疗结果:一项三级中心结局的系统评价与分析
Thorac Cardiovasc Surg. 2018 Oct;66(7):552-562. doi: 10.1055/s-0037-1618578. Epub 2018 Jan 19.
8
Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism.性别作为急性症状性肺栓塞成年患者死亡率的一个预后因素。
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD013835. doi: 10.1002/14651858.CD013835.pub2.
9
Infective Endocarditis Among Women Who Inject Drugs.女性吸毒者中的感染性心内膜炎。
JAMA Netw Open. 2024 Oct 1;7(10):e2437861. doi: 10.1001/jamanetworkopen.2024.37861.
10
Inotropes for the prevention of low cardiac output syndrome and mortality for paediatric patients undergoing surgery for congenital heart disease: a network meta-analysis.正性肌力药物预防先天性心脏病患儿心脏手术低心排血量综合征和死亡率的效果:网状 Meta 分析。
Cochrane Database Syst Rev. 2024 Nov 26;11(11):CD013707. doi: 10.1002/14651858.CD013707.pub2.

本文引用的文献

1
Current AATS guidelines on surgical treatment of infective endocarditis.美国胸外科医师协会(AATS)目前关于感染性心内膜炎外科治疗的指南。
Ann Cardiothorac Surg. 2019 Nov;8(6):630-644. doi: 10.21037/acs.2019.10.05.
2
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.成人感染性心内膜炎:诊断、抗菌治疗和并发症处理:美国心脏协会医疗保健专业人员科学声明。
Circulation. 2015 Oct 13;132(15):1435-86. doi: 10.1161/CIR.0000000000000296. Epub 2015 Sep 15.
3
Infective endocarditis.
感染性心内膜炎。
Lancet. 2016 Feb 27;387(10021):882-93. doi: 10.1016/S0140-6736(15)00067-7. Epub 2015 Sep 1.
4
2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).2015年欧洲心脏病学会(ESC)感染性心内膜炎管理指南:欧洲心脏病学会(ESC)感染性心内膜炎管理工作组。认可机构:欧洲心胸外科学会(EACTS)、欧洲核医学协会(EANM)。
Eur Heart J. 2015 Nov 21;36(44):3075-3128. doi: 10.1093/eurheartj/ehv319. Epub 2015 Aug 29.
5
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.金黄色葡萄球菌感染:流行病学、病理生理学、临床表现及管理
Clin Microbiol Rev. 2015 Jul;28(3):603-61. doi: 10.1128/CMR.00134-14.
6
In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis.行早期手术治疗的人工瓣膜心内膜炎患者的院内和 1 年死亡率。
JAMA Intern Med. 2013 Sep 9;173(16):1495-504. doi: 10.1001/jamainternmed.2013.8203.
7
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.21世纪感染性心内膜炎的临床表现、病因及转归:国际心内膜炎协作组前瞻性队列研究
Arch Intern Med. 2009 Mar 9;169(5):463-73. doi: 10.1001/archinternmed.2008.603.
8
Staphylococcus aureus endocarditis: a consequence of medical progress.金黄色葡萄球菌性心内膜炎:医学进步的一个后果。
JAMA. 2005 Jun 22;293(24):3012-21. doi: 10.1001/jama.293.24.3012.
9
Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.对杜克感染性心内膜炎诊断标准的拟议修改。
Clin Infect Dis. 2000 Apr;30(4):633-8. doi: 10.1086/313753. Epub 2000 Apr 3.